Form 4 for AARD Aardvark Therapeutics, Inc.
Accepted 2025-02-19 00:00:00 ET · period of report 2025-02-14 · accession 0000950170-25-023253 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-19 | 2025-02-14 | AARD | Lee Tien-Li | CEO, Dir, 10% | P - Purchase | $16.00 | +16.5K | 1.50M | +1% | +$264.7K |
| D | 2025-02-19 | 2025-02-14 | AARD | Lee Tien-Li | CEO, Dir, 10% | C - Cnv Deriv | — | +41.3K | 1.48M | +3% | — |
| D | 2025-02-19 | 2025-02-14 | AARD | Lee Tien-Li | CEO, Dir, 10% | C - Cnv Deriv | $0.00 | -350.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-14 | P | A | 16,542 | $16.00 | 1,496,175 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-14 | C | A | 41,303 | — | 1,479,633 | D | — | — | (F1) The Series A Convertible Preferred Stock of Aardvark Therapeutics, Inc. (the "Issuer") automatically converted on an 8.474-for-1 basis into shares of the Issuer's common stock ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The Series A Convertible Preferred Stock had no expiration date. |
| 3 | Derivative | Series A Convertible Preferred Stock | 2025-02-14 | C | D | 350,002 | $0.00 | 0 | D | — · — to — | 41,303 Common Stock | (F1) The Series A Convertible Preferred Stock of Aardvark Therapeutics, Inc. (the "Issuer") automatically converted on an 8.474-for-1 basis into shares of the Issuer's common stock ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The Series A Convertible Preferred Stock had no expiration date. |